ArisGlobal, a Miami, FL-based provider of life sciences software designed to automate core drug development functions, acquired Sporify, a Dublin, Ireland-based company focused on consistent and ISO IDMP-compliant SPOR data to feed regulatory activities across the product life cycle.
The amount of the deal was not disclosed.
With the acquisition, ArisGlobal will enhance its regulatory solutions with data governance capabilities; matching, maintaining, synchronizing, and integrating SPOR data for life sciences customers.
Sporify provides consistent and ISO IDMP-compliant SPOR data to feed regulatory activities across the product life cycle, enabling more informed, proactive regulatory decisions to benefit public health and safety. It is a SPOR data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies and several European regulators.
Led by CEO Mike Gordon, ArisGlobal is the creator of LifeSphere, a platform which specializes in global drug development technology solutions. It integrates its proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with expertise and a long-term perspective that spans almost 40 years, LifeSphere boosts efficiency, ensures compliance, and reduces cost through multi-tenant Software-as-a-Service (SaaS) architecture.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
FinSMEs
16/05/2023